Tuesday, December 7, 2021
Pasithea Therapeutics Corp. (NASDAQ: KTTA) Shares Skyrocket After Approval to Offer Esketamine Nasal Spray at its U.K. Clinics
Pasithea Therapeutics Corp. (NASDAQ: KTTA) is engaged as a U.S.-based biotechnology company, which is focused on the research, development and...
Read more
iSpecimen, Inc. (NASDAQ: ISPC) Announces Agreement with U.S. Government and Private Researchers to Supply Human Biospecimens for Advanced COVID-19 Research
iSpecimen, Inc. (NASDAQ: ISPC) is engaged as an online marketplace for human biospecimens. Seeking to connect life scientists with healthcare...
Read more
Longeveron, Inc. (NASDAQ: LGVN) Shares Skyrocket 175% After U.S. FDA Approves Lomecel-B for Rare Pediatric Disease Designation
Longeveron, Inc. (NASDAQ: LGVN) is engaged as a clinical-stage biotechnology company, which is specifically focused on the research, development and...
Read more
BIMI International Medical, Inc. (NASDAQ: BIMI) Reports Third Quarter 2021 Revenue Growth of 345%, Shares Surge over 50%
BIMI International Medical, Inc. (NASDAQ: BIMI) is engaged as a healthcare products and services provider, which operates four key segments:...
Read more
Unity Biotechnology, Inc. (NASDAQ: UBX) Provides Update on UBX1325 Clinical Studies, Releases Third Quarter Financial Results
Unity Biotechnology, Inc. (NASDAQ: UBX) is engaged in the research, testing and development of novel therapeutics to slow, halt or...
Read more
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) Sees STENDRA Sales Surge 476% Year-over-Year Due to Hims & Hers Health, Inc. (NYSE: HIMS) Collaboration
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is engaged as a specialized men’s health company, which is focused on the research, development,...
Read more
HCW Biologics, Inc. (NASDAQ: HCWB) Shares Soar After FDA Provided Clearance for HCW9218’s Phase 1b Clinical Trial for Treatment of Pancreatic Cancer
HCW Biologics, Inc. (NASDAQ: HCWB) is engaged as a biotechnology company, which is primarily focused on the research, discovery and...
Read more
Inspira Technologies (NASDAQ: IINN) Enters into Strategic Agreement with Waas Group to Send 1,040 ART Systems Across Spain and Portugal
Inspira Technologies (NASDAQ: IINN) is engaged as an Israeli medical device company, which focuses on research, development and commercialization of...
Read more
Radius Health, Inc. (NASDAQ: RDUS) and Menarini Group Unveiled Positive Phase 3 Topline Results from EMERALD Trial for Breast Cancer
Radius Health, Inc. (NASDAQ: RDUS) is engaged as a global biopharmaceutical company, which is focused on unmet medical needs in...
Read more
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Provides Update on ZYESAMI’s Commercial Scaling Efforts
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) is engaged as a clinical-stage, small molecule pharmaceutical company, which primarily focuses on developing therapies...
Read more
